Arnaud Denis, a 43-year-old French theatre director and actor, died by voluntary euthanasia in Namur, Belgium, following three years of severe health challenges linked to a hernia implant. Denis’s decision to end his life came after prolonged suffering, which he described as “multiple and degrading,” caused by complications from the implant.
In a posthumous message shared on his Facebook page, Denis expressed frustration with ongoing medical treatment, stating, “I’m done with medical mistreatment.” His lawyer, Philippe Courtois, confirmed that Denis’s choice followed consultations with three doctors. Courtois noted that Denis’s pain had become unbearable and that his body had ceased to sustain him.
Denis had a notable career in the theatre world. He won the best show prize in 2024 from the Association of Theatre Critics for his staging of *Liaisons Dangereuses* in Paris. In addition to his directing work, he appeared in well-known French television soap operas, including *Plus Belle la Vie*.
The hernia implant Denis received was manufactured by Medtronic. He accused the device of causing extensive internal damage, affecting his immunity, digestion, and sexuality. Denis also cited inadequate responses from leading Parisian hospitals, describing himself as a “victim of repeated medical errors.” Recently, a U.S. federal jury ordered Medtronic to pay $88 million in damages to an Alabama man and his wife in a related case concerning the implant.
Denis’s death occurred amid shifting legal landscapes regarding assisted dying in France and Belgium. Belgium permits euthanasia under broader conditions than France, where a new law was passed this summer. The French legislation allows assisted dying for individuals in advanced or terminal phases of serious, incurable, and life-threatening conditions but with stricter criteria than Belgian regulations. This law, however, has not yet been implemented.
Denis’s case highlights ongoing debates about medical ethics, patient rights, and the regulation of assisted dying in Europe.